GO:0030956 glutamyl-tRNA(Gln) amidotransferase complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030956 describes the glutamyl-tRNA(Gln) amidotransferase complex, a heterotrimeric enzyme that produces Gln-tRNA(Gln) by amidating Glu-tRNA(Gln).
• The complex is composed of GatA, GatB, and GatC subunits in bacteria and organelles, while some archaea use a GatCAB variant and certain organisms may lack GatC.
• It is essential in many bacteria, mitochondria, and plastids because these systems lack a canonical glutaminyl-tRNA synthetase for Gln-tRNA formation.
• Pathogenic variants in GATC, GATB, and GATA cause a lethal mitochondrial cardiomyopathy disorder in humans.
• The catalytic mechanism involves a serine-based glutaminase site in GatA that generates ammonia for transfer to Glu-tRNA.
• Research tools include Ribo-seq, proteomics, structural biology, and CRISPR knockout/knock-in models to dissect subunit function and disease mechanisms.
Description
The glutamyl-tRNA(Gln) amidotransferase complex (GO:0030956) is a cellular component defined by its ability to convert Glu-tRNA(Gln) into Gln-tRNA(Gln) through amidation. This indirect pathway of glutamine-tRNA synthesis is essential in organisms and organelles that lack a dedicated glutaminyl-tRNA synthetase, including many bacteria, mitochondria, and plastids. The complex typically consists of three subunits, GatA, GatB, and GatC, although the C subunit may be dispensable in some archaea. The complex sits at the intersection of translation and amino acid metabolism, ensuring that glutamine is correctly incorporated into proteins. In humans, biallelic pathogenic variants in GATC, GATB, or GATA cause a severe mitochondrial cardiomyopathy disorder, highlighting its clinical importance. Structural and biochemical studies have revealed a dynamic assembly that binds tRNA and uses a catalytic mechanism reminiscent of amidotransferases. For researchers, GO:0030956 provides a framework to study translation fidelity, organellar gene expression, and disease mechanisms. Understanding its components, assembly, and regulation enables targeted experiments using CRISPR models, proteomics, and structural approaches.
glutamyl-tRNA(Gln) amidotransferase complex At A Glance
| GO ID | GO:0030956 |
|---|---|
| GO term | glutamyl-tRNA(Gln) amidotransferase complex |
| Ontology | cellular_component |
| Synonym | AdT, GatCAB, GatFAB |
| Major function | Amidation of Glu-tRNA(Gln) to Gln-tRNA(Gln) |
| Subunit composition | Typically GatA, GatB, and GatC; GatC may be absent in some archaea |
| Cellular location | Cytoplasm in bacteria; mitochondria and plastids in eukaryotes |
| Catalytic activity | Glutamyl-tRNA(Gln) amidotransferase |
| Pathology | Pathogenic variants cause lethal mitochondrial cardiomyopathy |
What Is GO:0030956?
GO:0030956, glutamyl-tRNA(Gln) amidotransferase complex, is a protein complex that possesses glutamyl-tRNA(Gln) amidotransferase activity. It creates Gln-tRNA by amidating Glu-tRNA. The complex is usually composed of three subunits: A, B, and C, though the C subunit may not be required in all organisms.
Why Is glutamyl-tRNA(Gln) amidotransferase complex Important in Cell Biology?
The glutamyl-tRNA(Gln) amidotransferase complex is essential for accurate protein synthesis in many organisms and organelles that lack a canonical glutaminyl-tRNA synthetase. Its activity ensures that glutamine is incorporated into proteins, and its dysfunction leads to severe mitochondrial cardiomyopathy in humans. Studying this complex provides insights into translation, tRNA modification, and organellar biology, and it offers a target for antibiotic development and disease modeling.
• Essential for Gln-tRNA(Gln) synthesis in bacteria, mitochondria, and plastids.
• Pathogenic variants in GATC, GATB, and GATA cause lethal mitochondrial cardiomyopathy.
• Provides a model for RNA-dependent amidotransferase mechanisms.
• Represents a potential antibiotic target due to its essentiality in many pathogens.
• Involved in translation fidelity and amino acid metabolism.
• Studied using structural biology, proteomics, and CRISPR models.
• Links tRNA biology to organellar gene expression.
• Enables comparative studies of archaeal and bacterial translation systems.
Structure and Composition of glutamyl-tRNA(Gln) amidotransferase complex
Subunit Composition and Assembly
In simple terms: The complex is built from three different protein subunits that come together to form a working machine.
The glutamyl-tRNA(Gln) amidotransferase complex typically consists of three subunits: GatA, GatB, and GatC. In bacteria such as Bacillus stearothermophilus, the enzyme has been expressed, purified, and crystallized, confirming a heterotrimeric arrangement. Some archaea use a GatCAB variant, and the C subunit may be dispensable in certain organisms. The assembly is essential for catalytic activity, as the subunits cooperate to bind tRNA and catalyze amidation.
GatA: The Glutaminase Subunit
In simple terms: GatA is the part that breaks down glutamine to release ammonia for the reaction.
GatA contains a serine-based glutaminase site that hydrolyzes glutamine to generate ammonia, which is then used to amidate Glu-tRNA. Mutagenesis and mechanism-based inhibition studies in Streptococcus pyogenes have implicated this serine residue in catalysis. The ammonia is channeled to the GatB subunit for transfer to the tRNA-bound glutamate.
GatB: The tRNA-Binding and Amidation Subunit
In simple terms: GatB holds the tRNA and performs the actual amidation reaction.
GatB binds the Glu-tRNA(Gln) substrate and catalyzes the transfer of ammonia to the glutamate moiety, forming Gln-tRNA(Gln). Structural studies of the archaeal transamidosome have revealed how GatB recruits tRNA and coordinates with GatA for efficient amidation. The GatB subunit is essential for the overall reaction and is conserved across bacteria and organelles.
GatC: The Structural and Regulatory Subunit
In simple terms: GatC helps hold the complex together and may regulate its activity.
GatC is a small subunit that facilitates the assembly and stability of the GatA-GatB complex. In some archaea, GatC is not required, and the complex functions as a GatAB dimer or with a different subunit arrangement. In humans, pathogenic variants in GATC cause mitochondrial cardiomyopathy, underscoring its importance.
Cellular Localization and Organellar Targeting
In simple terms: In eukaryotes, the complex is found in mitochondria and plastids, where it supports organellar translation.
In bacteria, the complex is cytoplasmic, while in eukaryotes it is targeted to mitochondria and plastids. This localization is consistent with the lack of a glutaminyl-tRNA synthetase in these organelles, necessitating the indirect pathway for Gln-tRNA synthesis. The Chlamydomonas reinhardtii enzyme was purified from chloroplasts, demonstrating its presence in plastids.
Key Genes Involved in GO:0030956 glutamyl-tRNA(Gln) amidotransferase complex
The following genes and proteins are core components or associated factors of the glutamyl-tRNA(Gln) amidotransferase complex.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GATA | Encodes GatA subunit with glutaminase activity | Mutations cause mitochondrial cardiomyopathy |
| GATB | Encodes GatB subunit that binds tRNA and catalyzes amidation | Mutations cause mitochondrial cardiomyopathy |
| GATC | Encodes GatC subunit for complex assembly and stability | Mutations cause mitochondrial cardiomyopathy |
| gatA (bacterial) | Glutaminase subunit in bacteria | Antibiotic target and structural studies |
| gatB (bacterial) | Amidation subunit in bacteria | Essential for Gln-tRNA synthesis |
| gatC (bacterial) | Assembly subunit in bacteria | May be dispensable in some archaea |
| GatCAB (archaeal) | Archaeal transamidosome component | Model for RNA-dependent amidotransferase |
| GatFAB | Alternative complex in some organisms | Related to GatCAB but with different subunit composition |
| QRS (glutaminyl-tRNA synthetase) | Direct pathway for Gln-tRNA synthesis | Absent in organisms using the indirect pathway |
| tRNA(Gln) | Substrate for amidation | Central to translation fidelity |
| Glu-tRNA(Gln) | Substrate that is amidated | Key intermediate in the pathway |
| Gln-tRNA(Gln) | Product of the reaction | Directly used in protein synthesis |
| AdT (bacterial) | Bacterial amidotransferase complex | Biochemical and structural studies |
| GatA homologs | Glutaminase domain proteins | Evolutionary and functional studies |
| GatB homologs | Amidation domain proteins | Conserved across kingdoms |
| GatC homologs | Small subunit homologs | Assembly and regulation |
| Mitochondrial GatCAB | Organellar complex | Disease modeling and mitochondrial translation |
How Is glutamyl-tRNA(Gln) amidotransferase complex Regulated?
The expression and activity of the glutamyl-tRNA(Gln) amidotransferase complex are regulated at multiple levels. In bacteria, the gatA, gatB, and gatC genes are often co-transcribed as an operon, ensuring stoichiometric production of subunits. In eukaryotes, mitochondrial import and assembly factors regulate complex formation. The catalytic activity can be modulated by substrate availability, particularly Glu-tRNA and glutamine. Additionally, the archaeal transamidosome forms a dynamic complex with tRNA and glutaminyl-tRNA synthetase, suggesting regulation by tRNA availability.
glutamyl-tRNA(Gln) amidotransferase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GATC | Lethal mitochondrial cardiomyopathy | Knockout or point-mutation in human cells |
| GATB | Lethal mitochondrial cardiomyopathy | Knockout or point-mutation in human cells |
| GATA | Lethal mitochondrial cardiomyopathy | Knockout or point-mutation in human cells |
| GatCAB (bacterial) | Antibiotic target | Bacterial knockout and inhibition assays |
| Archaeal GatCAB | Translation mechanism | In vitro reconstitution and structural studies |
Mitochondrial Cardiomyopathy
Biallelic pathogenic variants in GATC, GATB, and GATA cause a lethal mitochondrial cardiomyopathy disorder characterized by early-onset heart failure and lactic acidosis. These mutations impair the amidotransferase activity, leading to defective mitochondrial translation and energy production.
Other Potential Disorders
While mitochondrial cardiomyopathy is the primary known disease, defects in tRNA modification and translation may contribute to broader neuromuscular and metabolic phenotypes. Further research is needed to establish links to other conditions.
From glutamyl-tRNA(Gln) amidotransferase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GATC cause mitochondrial dysfunction? | CRISPR knockout in human cardiomyocytes |
| Do patient variants impair amidotransferase activity? | Point-mutation knock-in in cell lines |
| Can wild-type GATC rescue the phenotype? | Knock-in of tagged GATC for rescue experiments |
| Is GatC required in archaea? | Knockout of gatC in archaeal models |
| What is the catalytic mechanism of GatA? | Overexpression and purification of mutant GatA |
| How does the complex assemble? | Tagged knock-in and affinity purification |
How to Study the glutamyl-tRNA(Gln) amidotransferase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | Three-dimensional structure | Subunit arrangement and tRNA binding |
| Cryo-EM | Structure of large complexes | Transamidosome architecture |
| In vitro amidotransferase assay | Enzymatic activity | Kinetics and inhibition |
| Affinity purification-MS | Protein interactions | Assembly and partner identification |
| Ribo-seq | Translation efficiency | Mitochondrial translation defects |
| CRISPR knockout | Gene function | Disease modeling |
| Site-directed mutagenesis | Residue function | Catalytic mechanism |
Structural Biology
X-ray crystallography and cryo-EM have been used to determine the structure of the glutamyl-tRNA(Gln) amidotransferase complex, revealing subunit interactions and tRNA binding. Crystallization of the Bacillus stearothermophilus enzyme provided early structural insights.
Biochemical Assays
In vitro amidotransferase assays measure the conversion of Glu-tRNA to Gln-tRNA using radiolabeled substrates or mass spectrometry. Purification of the complex from Chlamydomonas reinhardtii enabled functional characterization.
Proteomics and Interaction Studies
Affinity purification coupled with mass spectrometry can identify interacting partners and assembly intermediates. The archaeal transamidosome was characterized using such approaches.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes required for mitochondrial translation and amidotransferase function. These screens help link genotype to phenotype in disease models.
How CRISPR Can Be Used to Study GO:0030956 glutamyl-tRNA(Gln) amidotransferase complex
Knockout
CRISPR knockout of GATC, GATB, or GATA in human cell lines can model the loss of amidotransferase activity and reveal mitochondrial translation defects. Knockout in bacteria can validate essentiality and antibiotic targets.
Point Mutation
Introducing patient-specific point mutations into GATC, GATB, or GATA using CRISPR base editing or HDR can recapitulate the mitochondrial cardiomyopathy phenotype. These models help distinguish pathogenic variants from benign polymorphisms.
Knock-in
Tagged knock-in of GatA, GatB, or GatC allows affinity purification and live-cell imaging of the complex. Knock-in of wild-type alleles can rescue knockout phenotypes.
Overexpression
Overexpression of the complex subunits in bacteria or human cells can produce sufficient material for structural and biochemical studies. It can also test dominant-negative effects of mutant subunits.
How EDITGENE Supports glutamyl-tRNA(Gln) amidotransferase complex Research
Researchers studying glutamyl-tRNA(Gln) amidotransferase complex-related genes often need to determine whether a candidate gene is causally involved in mitochondrial translation, disease pathogenesis, or antibiotic susceptibility. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for glutamyl-tRNA(Gln) amidotransferase complex research.
Frequently Asked Questions About glutamyl-tRNA(Gln) amidotransferase complex
What is the glutamyl-tRNA(Gln) amidotransferase complex?
It is a protein complex (GO:0030956) that converts Glu-tRNA(Gln) to Gln-tRNA(Gln) by amidation, typically composed of GatA, GatB, and GatC subunits.
What genes are involved in the glutamyl-tRNA(Gln) amidotransferase complex?
The core genes are GATA, GATB, and GATC in humans, and gatA, gatB, gatC in bacteria.
What diseases are associated with glutamyl-tRNA(Gln) amidotransferase complex mutations?
Pathogenic variants in GATC, GATB, and GATA cause a lethal mitochondrial cardiomyopathy disorder.
Where is the glutamyl-tRNA(Gln) amidotransferase complex located?
In bacteria it is cytoplasmic; in eukaryotes it is found in mitochondria and plastids.
What is the function of GatA?
GatA is the glutaminase subunit that generates ammonia from glutamine for the amidation reaction.
What is the function of GatB?
GatB binds Glu-tRNA and catalyzes the transfer of ammonia to form Gln-tRNA.
What is the function of GatC?
GatC is a small subunit that facilitates assembly and stability of the complex, though it may be dispensable in some archaea.
How is the glutamyl-tRNA(Gln) amidotransferase complex studied?
Common methods include X-ray crystallography, cryo-EM, in vitro activity assays, and CRISPR knockout models.
Is the glutamyl-tRNA(Gln) amidotransferase complex essential?
Yes, it is essential in organisms and organelles that lack a glutaminyl-tRNA synthetase, as it provides the only route for Gln-tRNA synthesis.
Can CRISPR be used to model glutamyl-tRNA(Gln) amidotransferase complex diseases?
Yes, CRISPR knockout and point-mutation knock-in models can recapitulate mitochondrial cardiomyopathy phenotypes.
Conclusion
The glutamyl-tRNA(Gln) amidotransferase complex (GO:0030956) is a critical enzyme for Gln-tRNA synthesis in many bacteria, mitochondria, and plastids. Its dysfunction causes severe mitochondrial cardiomyopathy, making it an important target for disease modeling and therapeutic development. Continued research using structural biology, proteomics, and CRISPR models will further illuminate its mechanism and regulation.
References
- 1. Friederich MW et al.. 2018. Pathogenic variants in glutamyl-tRNA(Gln) amidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder.. Nat Commun 9(1):4065 PMID: 30283131
- 2. Kwak JH et al.. 2002. Expression, purification, and crystallization of glutamyl-tRNA(Gln) specific amidotransferase from Bacillus stearothermophilus.. Mol Cells 14(3):374-81 PMID: 12521300
- 3. Jahn D et al.. 1990. Purification and functional characterization of the Glu-tRNA(Gln) amidotransferase from Chlamydomonas reinhardtii.. J Biol Chem 265(14):8059-64 PMID: 1970821
- 4. Rampias T et al.. 2010. The archaeal transamidosome for RNA-dependent glutamine biosynthesis.. Nucleic Acids Res 38(17):5774-83 PMID: 20457752
- 5. Oshikane H et al.. 2006. Structural basis of RNA-dependent recruitment of glutamine to the genetic code.. Science 312(5782):1950-4 PMID: 16809540
- 6. Harpel MR et al.. 2002. Mutagenesis and mechanism-based inhibition of Streptococcus pyogenes Glu-tRNAGln amidotransferase implicate a serine-based glutaminase site.. Biochemistry 41(20):6398-407 PMID: 12009902
- 7. Deniziak M et al.. 2007. Deinococcus glutaminyl-tRNA synthetase is a chimer between proteins from an ancient and the modern pathways of aminoacyl-tRNA formation.. Nucleic Acids Res 35(5):1421-31 PMID: 17284460
- 8. Bhaskaran H et al.. 2011. Two-step aminoacylation of tRNA without channeling in Archaea.. J Mol Biol 411(4):854-69 PMID: 21726564
